Invention Grant
- Patent Title: Use of chloroquine to treat metabolic syndrome
- Patent Title (中): 使用氯喹治疗代谢综合征
-
Application No.: US12093198Application Date: 2006-10-31
-
Publication No.: US08440695B2Publication Date: 2013-05-14
- Inventor: Michael B. Kastan , Clay F. Semenkovich , Jochen Schneider
- Applicant: Michael B. Kastan , Clay F. Semenkovich , Jochen Schneider
- Applicant Address: US TN Memphis US MO St. Louis
- Assignee: St Jude Children's Research Hospital,The Washington University
- Current Assignee: St Jude Children's Research Hospital,The Washington University
- Current Assignee Address: US TN Memphis US MO St. Louis
- Agency: Fish & Richardson P.C.
- International Application: PCT/US2006/060391 WO 20061031
- International Announcement: WO2007/059372 WO 20070524
- Main IPC: A61K31/47
- IPC: A61K31/47

Abstract:
The present invention provides methods and compositions for modulating certain metabolic processes and for treating a variety of disorders associated with metabolic syndrome, including insulin related disorders, ischemia, oxidative stress, atherosclerosis, hypertension, obesity, abnormal lipid metabolism, and stroke by administering an effective dose of a chloroquine compound. The invention also provides methods and compositions relating to administering an effective dose of a chloroquine compound in combination with at least a second pharmaceutically active ingredient or compound including an antihyperglycemic diabetes treatment, an antihypertensive agent, an antithrombotic agent, and/or an inhibitor of cholesterol synthesis or absorption.
Public/Granted literature
- US20080319010A1 Use of Chloroquine to Treat Metabolic Syndrome Public/Granted day:2008-12-25
Information query